22nd Century Group (XXII) Says Phase III Study using its SPECTRUM Research Cigarettes Shows Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

Go back to 22nd Century Group (XXII) Says Phase III Study using its SPECTRUM Research Cigarettes Shows Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

October 6, 2017 6:30 AM EDT

Minimally or non-addictive Very Low Nicotine cigarettes are the ultimate harm reduction strategy

CLARENCE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, announced today that Dr. Dorothy Hatsukami, at the Vermont Center on Behavior and Healths 5th Annual Conference on... More